Professional Experience

Ms. Krasner has extensive expertise in federal healthcare programs in areas including Medicare coverage, pharmaceutical reimbursement, and Medicare and Medicaid managed care arrangements. In particular, she has a unique expertise with regard to the legal, regulatory and policy implications of the new prescription drug benefit now offered under Medicare and how the new benefit interacts with the many other facets of our healthcare system.

Prior to joining Manatt, Ms. Krasner worked as Deputy Vice President for Policy at the Pharmaceutical Research and Manufacturers of America (the trade association for brand-name pharmaceutical manufacturers known as PhRMA). There, she played a prominent role in the development of the new Medicare prescription drug benefit. Before joining PhRMA in 2003, she was a partner at the Washington, D.C. office of McDermott Will & Emery, where she practiced healthcare law for over 23 years.

Education

University of California, Berkeley, Boalt Hall School of Law, J.D., 1978
Order of the Coif.

Harvard University , B.A., cum laude, 1975.

Memberships & Activities

Admitted to practice in the state of California and the District of Columbia.

Chair, Life Sciences Practice Group, American Health Lawyers Association.

Member, Editorial Advisory Board, BNA Life Sciences Law & Industry Report,
2007-present.

Member, BNA Health Plan and Provider Advisory Board, 2000-present.

Member, Editorial Advisory Board, United States Healthcare Laws and Rules, 2002-2003, 2004-2005, and 2006-2007 editions.

Board Member, Cradle of Hope (International Adoption Agency), 1995-1999.

Board Member, Visiting Nurse Association of Washington, D.C., 1990-1995.

Instructor, Johns Hopkins School of Medicine, 1995-1998.

Honors & Awards

Leading U.S. Healthcare Lawyers, 2005. 

Best Health Lawyers in U.S., 1997-1998, 1999-2000, 2001-2002, 2003-2004.

Publications

Co-Author, “Significant Federal Endorsement of Incentive Payments to Drive E-Prescribing Adoption,” BNA’s Health Plan & Provider Report 14(30), July 16, 2008.

Contributor, “Federal Preemption: U.S. High Court Cases Leave Circuits Split on Fraud-on-FDA, Attorneys Say Congress May Have to Revisit Preemption Issue,” BNA’s Life Sciences Law & Industry Report 2(6), March 14, 2008.

Co-Author, “Medicare Part D Compliance,” 2008 Health Law and Compliance Update, Aspen Publishers, 2008.

Contributor, “Insurance Reform, Access, Medicare Advantage, Health IT Issues Loom in 2008,” BNA’s Health Plan & Provider Report 14(3), January 16, 2008.

Contributor, “Experts Predict Which Life Sciences Issues Will Predominate in 2008,” BNA’s Life Sciences Law & Industry Report 2(1), January 4, 2008.

Co-Author, “Private Medicare Drug Plans:  High Expenses and Low Rebates Increase the Costs of Medicare Drug Coverage,” Life Sciences Practice Group E-mail Alert, American Health Lawyers Association, October 16, 2007.

Co-Author, “Vaccine Administration and Access Update:  Beneficiaries to Receive Greater Access to Vaccines in 2008,” Life Sciences Law & Industry Report 1(13), September 14, 2007.

Co-Author, “Part D Formularies:  The Ongoing Battleground between Access and Cost,” Chapter in Health Law Handbook, Thompson/West, May 2007.

Co-Author, “CMS Issues 2008 Part D Vaccine Guidance Summary,” Life Sciences Practice Group E-mail Alert, American Health Lawyers Association, May 15, 2007.

Co-Author, “Summary of Baucus Proposed Legislation to Strike the Non-Interference Clause,” American Health Lawyers Association Practice Group E-mail Alert, April 11, 2007.

Co-Author, “New Developments in Part D Vaccine Administration and Access,” BNA's Health Plan & Provider Report , January 10, 2007.

Co-Author, “Key Changes Made in Final Chapter 9 of the Prescription Drug Benefit Manual,” Health Lawyers Weekly, May 5, 2006.

Co-Author, “Client Advisory - CMS Releases Draft Fraud Waste and Abuse Chapter for the Prescription Drug Benefit Manual,” Manatt, Phelps & Phillips, LLP, February 2006.

Co-Author, “Client Advisory - Significant Changes To Medicaid in Federal Deficit Reduction Action of 2005,” Manatt, Phelps & Phillips, LLP, February 2006.

Co-Author, “Part D Challenges,” Health Lawyers Weekly, October 28, 2005.

Co-Author, “6.4 Million at Risk: Protecting the Poorest Americans During the Medicare Drug Transition,” Medicare Rights Center, October 2005.

Co-Author, “Medicaid Managed Care Final Rules,” AHLA HMOs and Health Plans Practice Group: Member Briefing.

Author, “Plan Liability: Good News and Bad News From First Major Florida MDL Ruling,” Managed Care Law Strategist.

Author, “Medicare+Choice: Regulations, Contracts, and Policies,” Health Law Handbook.

Author, “Medicare Outpatient Prescription Drug Benefits: Lessons Learned from M+C?” BNA’s Medicare Report.

Author, “Integrating Accreditation Activities into Your Compliance Program,” Today’s Corporate Compliance.

Author, “Implications of Compliance with QISMC,” Today’s Corporate Compliance.

Author, “OIG Draft Compliance Program Guidance for Medicare+Choice Organizations,” Today’s Corporate Compliance.

Author, “Compliance Uncertainty: How to Proceed in an Unpredictable Regulatory Environment,” Today’s Corporate Compliance.

Speaking Engagements

Speaker, “Implementing and Managing Effective Fraud, Waste and Abuse Programs,” Financial Research Association Conference, Washington, DC, March 31, 2008.

Speaker, “Part D- Key Legal, Regulatory and Contractual  Developments,” AHLA Life Sciences Annual Conference, San Francisco, CA, April 2007.

Panelist, “‘Medicare Part D Formularies’:  How do they look and how are they working?” Medicare Part D:  What is the Future?, Strategic Research Institute, Arlington, VA , October 26, 2006.

Panelist, “Helping People Afford their Part D Medications:  Where to Turn for Help,” Blue Skies and Brickwork II:  Making the Most of the Medicare Prescription Drug Benefit, Lansdowne, VA, September 19, 2006.

Speaker, “Part D Compliance,” Managed Care Law Conference, American Health Lawyers Association, May 2006.

Speaker, “Part D Compliance for Teaching Hospitals,” Compliance Institute, Association of American Medical Colleges, May 2006.

Speaker, “Part D Formulary Legal Issues,” Life Sciences Law Institute, American Health Lawyers Association, April 2006.

Speaker, “Impact of Part D on Pharmaceutical Industry,” American Health Lawyers Association, 2005.

Speaker, “Legal Issues Raised by Adding Pharmacy Benefit to Medicare,” American Health Lawyers Association, 2003.

Speaker, “The OIG Draft Pharmaceutical Compliance Guidelines: Implications for Health Plans,” Blue Cross and Blue Shield Association, 2002.